{"schema_version":"secwatch.filing_event.v1","accession":"0001145197-24-000021","form_type":"8-K","ticker":"PODD","cik":"0001145197","company_name":"INSULET CORP","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.465250+00:00","generated_at":"2026-06-02T04:54:59.671667+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Insulet Q1 revenue $441.7M (+23% YoY); raises full-year guidance","bullets":["Q1 revenue $441.7M, +23.3% YoY, above guidance of 17-20% constant currency; Omnipod revenue $433.0M.","Net income $51.5M ($0.73 diluted EPS) vs $23.8M ($0.34) prior year; operating margin 12.9% (up 520 bps).","Gross margin 69.5% (up 230 bps); adjusted EBITDA $89.2M (20.2% of revenue) up from 13.6%.","Raised full-year guidance; launched Omnipod 5 with Dexcom G7 in US and with Abbott/Sensor of Choice in Europe."],"urls":{"canonical":"https://secwatch.observer/filing/0001145197-24-000021","json":"https://secwatch.observer/filing/0001145197-24-000021.json","markdown":"https://secwatch.observer/filing/0001145197-24-000021.md","text":"https://secwatch.observer/filing/0001145197-24-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/0001145197-24-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/podd-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:54:59.671667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ebf299fd317e3ca10c435280f4ad1b543f2294a","claim":"INSULET CORP updated its Full Year 2024 guidance (raised).","evidence_excerpt":"Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year Raising Full Year Revenue and Operating Margin Guidance","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/0001145197-24-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2024"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"8ed06898265ace9368a1c984c995e34a024b8419","claim":"INSULET CORP reported first quarter ended March 31, 2024 results: revenue 441.7 million, net income 51.5 million, EPS 0.73. Guidance raised.","evidence_excerpt":"First quarter 2024 revenue of $441.7 million, up 23.3%, or 22.8% in constant currency 1 , compared to $358.1 million in the prior year, exceeds the guidance range of 17% to 20% in constant currency due to revenue outperformance for all product lines","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1145197/000114519724000021/0001145197-24-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"441.7 million"},{"label":"Net income","value":"51.5 million"},{"label":"EPS","value":"0.73"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}